# Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

> **NCT07382128** · — · RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 250 (estimated)

## Conditions studied

- HCM - Hypertrophic Cardiomyopathy
- Anderson Fabry Disease
- Cardiac Magnetic Resonance Imaging
- Amyloid Cardiomyopathy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07382128
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07382128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07382128, "Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07382128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*